finchtherapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.finchtherapeutics.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Home — Finch
Description Finch, an early pioneer in the emerging field of microbiome therapeutics, has established a leading portfolio of innovative microbiome assets with potential applicability to a wide range of product strategies and therapeutic
Keywords N/A
Server Information
WebSite finchtherapeutics faviconfinchtherapeutics.com
Host IP 104.26.15.223
Location United States
Related Websites
Site Rank
More to Explore
finchtherapeutics.com Valuation
US$50,883,137
Last updated: 2023-05-07 07:47:27

finchtherapeutics.com has Semrush global rank of 208,012. finchtherapeutics.com has an estimated worth of US$ 50,883,137, based on its estimated Ads revenue. finchtherapeutics.com receives approximately 5,871,132 unique visitors each day. Its web server is located in United States, with IP address 104.26.15.223. According to SiteAdvisor, finchtherapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$50,883,137
Daily Ads Revenue US$46,970
Monthly Ads Revenue US$1,409,072
Yearly Ads Revenue US$16,908,858
Daily Unique Visitors 391,409
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
finchtherapeutics.com. A 299 IP: 104.26.15.223
finchtherapeutics.com. A 299 IP: 172.67.72.166
finchtherapeutics.com. A 299 IP: 104.26.14.223
finchtherapeutics.com. AAAA 299 IPV6: 2606:4700:20::ac43:48a6
finchtherapeutics.com. AAAA 299 IPV6: 2606:4700:20::681a:fdf
finchtherapeutics.com. AAAA 299 IPV6: 2606:4700:20::681a:edf
finchtherapeutics.com. NS 86400 NS Record: norman.ns.cloudflare.com.
finchtherapeutics.com. NS 86400 NS Record: dawn.ns.cloudflare.com.
finchtherapeutics.com. MX 300 MX Record: 10 us-smtp-inbound-1.mimecast.com.
finchtherapeutics.com. MX 300 MX Record: 10 us-smtp-inbound-2.mimecast.com.
finchtherapeutics.com. TXT 300 TXT Record: have-i-been-pwned-verification=cc28a21411a7f2a639ec664b2bca192c
finchtherapeutics.com. TXT 300 TXT Record: v=spf1 include:us._netblocks.mimecast.com ip4:54.87.140.166 include:spf.protection.outlook.com -all
finchtherapeutics.com. TXT 300 TXT Record: 0ed1fe018a92c4477b3c394cb39bc1e82de6de6a04
finchtherapeutics.com. TXT 300 TXT Record: atlassian-domain-verification=XkNNBCkYnsE3iRhIQU+WwW8MaaECFfKqfuXC7rJQGNLx2WskSHmGQ7PkvWZwBNo3
HtmlToTextCheckTime:2023-05-07 07:47:27
About Leadership Board of Directors History Contact Us Portfolio Overview IP Estate Publications Investors & News Overview Stock Information Press Releases Events Publications Financials & Filings Corporate Governance Investor Resources Contact IR Home The microbiome: an exciting new modality Recurrent C. diff study now enrolling Learn more --> Finch has a portfolio of innovative microbiome assets Finch, an early pioneer in the microbiome field, has established a portfolio of innovative microbiome assets with potential applicability to a wide range of product strategies and therapeutic areas. In January 2023, Finch announced a decision to discontinue its Phase 3 trial of CP101 in recurrent C. difficile and focus on realizing the value of its IP estate and other assets. Our portfolio Finch has established a leading portfolio of microbiome assets designed with insights from human microbiota transplantation studies. Learn more IP estate Finch has a robust intellectual property estate
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Wed, 27 Oct 2021 15:32:48 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Pragma: no-cache
X-Redirect-By: WordPress
Location: https://www.finchtherapeutics.com/
X-Powered-By: WP Engine
X-Cacheable: non200
Cache-Control: max-age=600, must-revalidate
X-Cache: HIT: 2
X-Cache-Group: normal
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=k4hlTSpAcoFee3UqL7woYDpi9WExYuP883LePdIIXnJ8JSzWopwEkLCyy1KdjGk%2BG%2B1seBeCeRo%2BcOuXmdmK0pVs7aI6gHLXb7iBQid0yZL27rB7ouvqzQzITbqWEf0s7kjsywU0oA%3D%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a4cfaad9edf2c80-ORD

HTTP/2 200 
date: Wed, 27 Oct 2021 15:32:49 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
vary: Accept-Encoding
expires: Thu, 19 Nov 1981 08:52:00 GMT
pragma: no-cache
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-powered-by: WP Engine
x-cacheable: SHORT
vary: Accept-Encoding,Cookie
cache-control: max-age=600, must-revalidate
x-cache: HIT: 1
x-cache-group: normal
x-orig-cache-control: no-store, no-cache, must-revalidate
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=Mul9EilrzNnAGpSXGYkiAAwE7DHymWq4ihOLtNo42JNAZvKx2T1HXRTzwh%2BLvMLdspbjhEVkG0ey1PisrAbRtt%2BgoCyBNFznfP3iwN3X3B356a69PCe8McJJl4kClkAACmM%2BeekwLKmg63Q%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a4cfaae99782a99-ORD
finchtherapeutics.com Whois Information
Domain Name: FINCHTHERAPEUTICS.COM
Registry Domain ID: 2021008333_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.cloudflare.com
Registrar URL: http://www.cloudflare.com
Updated Date: 2021-02-02T12:01:39Z
Creation Date: 2016-04-12T17:48:08Z
Registry Expiry Date: 2030-04-12T17:48:08Z
Registrar: CloudFlare, Inc.
Registrar IANA ID: 1910
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DAWN.NS.CLOUDFLARE.COM
Name Server: NORMAN.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-15T11:56:13Z <<<